Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM50145471
Substrate
n/a
Meas. Tech.
Inhibition Assay
pH
7.5±n/a
IC50
1257.1±n/a nM
Comments
extracted
Citation
 Cho, HWu, YChoi, C Thiazolidinedione derivative and use thereof US Patent  US8637558 Publication Date 1/28/2014 
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Homo sapiens (Human)
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM50145471
Synonyms:
5-(4-(benzyloxy)benzyl)thiazolidine-2,4-dione | 5-(4-Benzyloxy-benzyl)-thiazolidine-2,4-dione | CHEMBL316370 | US8637558, 116 | US8637558, 124
Type:
Small organic molecule
Emp. Form.:
C17H15NO3S
Mol. Mass.:
313.371
SMILES:
Oc1[nH]c(=O)sc1Cc1ccc(OCc2ccccc2)cc1
Structure:
Search PDB for entries with ligand similarity: